REQUEST A DEMO
Total
USD $0.00
Search more companies

Su Otorrino & Caramia S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Su Otorrino & Caramia S.A.S. Profile Updated: July 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Su Otorrino & Caramia S.A.S. is a company based in Colombia, with its head office in Medellin. It operates in the Ambulatory Health Care Services industry. The company was established on June 01, 2018. 4 (2026) employees currently work for Su Otorrino & Caramia S.A.S.. From the latest financial highlights, Su Otorrino & Caramia S.A.S. reported a net sales revenue increase of 81.46% in 2025. Over the same period, its total assets grew by 208.19%. The net profit margin of Su Otorrino & Caramia S.A.S. increased by 21.02% in 2025.

Headquarters
Calle 7 39 197 Cs 1504
Medellin; Antioquia;

Contact Details: Purchase the Su Otorrino & Caramia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Su Otorrino & Caramia S.A.S. report to view the information.
Financial Auditors:
Purchase the Su Otorrino & Caramia S.A.S. report to view the information.
Incorporation Date:
June 01, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Su Otorrino & Caramia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
81.46%
Total Operating Revenue
81.46%
Operating Profit
1700.38%
Net Profit/Loss for the Period
8074.25%
Total Assets
208.19%
Total Equity
95.81%
Operating Profit Margin
19.33%
Net Profit Margin
21.02%
Return on Equity (ROE)
50.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?